Table 2.

Comparisons of routine investigations in different study groups.

		HCC (n= 40)	HCV (n= 40)	Control (n= 20)	p	Sig.
		Mean ± SD	Mean ± SD	Mean ± SD
CBC	Hb (gm/dl)	11.3 ± 2.6	13.4 ± 1.8	14.6 ± 0.89	< 0.001a, b	HS
					0.08c	NS
	TLC * 1000	5.6 ± 2.2	6.8 ± 2.5	7.5 ± 1.5	0.9a	NS
					0.01b	S
					0.8c	NS
	PLT	126.2 ± 77.8	213.3 ± 75.8	312.3 ± 45.9	< 0.001a,b,c	HS
Liver function tests	AST (U/L)	112.1 ± 64.4	46.4 ± 22.2	19.4 ± 6.8	< 0.001a,b,c	HS
	ALT (U/L)	80 ± 53.3	55.8 ± 27.1	20.8 ± 6.1	0.01a	S
					0.001b	HS
					0.003c	S
	ALP (U/L)	176.3 ± 147.6	122.7 ± 63.9	50.3 ± 14.6	0.06a	NS
					0.001b	HS
					0.03c	S
	Albumin	3.7 ± 1.3	3.8 ± 0.67	4.5 ± 0.29	0.9a	NS
					0.01b	S
					0.04c	S
		Median / IQR	Median / IQR	Median / IQR
	Total bilirubin (mg/dl)	1.5 / 1.1	0.9 / 0.28	0.7 / 0.18	0.001a	S
					0.001b	S
					0.008c	HS
	Direct bilirubin (mg/dl)	0.5 / 0.93	0.6 / 0.42	0.3 / 0.1	0.3a	NS
					< 0.001b,c	HS

^asignificance between HCC and HCV,

^bsignificance between HCC and control,

^csignificance between HCV and control.